Vimarsana
Biggest News Aggregation in the World

Page 47 - Practice Guidelines News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Practice Guidelines. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Practice Guidelines Today - Breaking & Trending Today

National Comprehensive Cancer Network: NCCN Global Policy Leader Named Co-Chair of Global Health Council Roundtable Advancing International Coordination in Cancer Care - Vimarsana News

National Comprehensive Cancer Network: NCCN Global Policy Leader Named Co-Chair of Global Health Council Roundtable Advancing International Coordination in Cancer Care

Katy Winckworth-Prejsnar, Senior Manager of Global Policy and Strategic Alliances for National Comprehensive Cancer Network, to Co-Chair Non-Communicable Diseases Roundtable PLYMOUTH MEETING

Health Care Resource Utilization, Quality Metrics, and Costs of Bladder Cancer Within the Oncology Care Model - Vimarsana News

Health Care Resource Utilization, Quality Metrics, and Costs of Bladder Cancer Within the Oncology Care Model

Spending on novel therapies in high-risk bladder cancer had minimal impact on Oncology Care Model payments to practices, according to this cohort study and an average performance estimation.

Source: ajmc.com
New tool launched to make ESMO Clinical Practice Guidelines easier to use in routine clinical practice - Vimarsana News

New tool launched to make ESMO Clinical Practice Guidelines easier to use in routine clinical practice

ESMO, the leading professional organization for medical oncology, today announced the launch of a new tool designed to make the renowned ESMO Clinical Practice Guidelines (CPGs) easier to use in oncologists' routine clinical practice and support optimal decision-making in a rapidly evolving medical field.

New Research Results Spotlight Rare Molecular Subtypes in NSCLC - Vimarsana News

New Research Results Spotlight Rare Molecular Subtypes in NSCLC

Although molecularly targeted therapies have transformed the treatment paradigm for NSCLC, the kaleidoscope of genomic alterations that affects subsets of patients is straining the limits of current diagnostic and clinical discovery approaches.

Servier receives European Commission approval of Tibsovo® (ivosidenib tablets) in IDH1-mutated Acute Myeloid Leukemia and IDH1-mutated Cholangiocarcinoma - Vimarsana News

Servier receives European Commission approval of Tibsovo® (ivosidenib tablets) in IDH1-mutated Acute Myeloid Leukemia and IDH1-mutated Cholangiocarcinoma

/PRNewswire/ -- Servier, a global pharmaceutical group, today announced that the European Commission (EC) has approved Tibsovo® (ivosidenib tablets) as a...